For private consultants, integrating cancer treatment at home is not about relinquishing control – it is about extending the reach of clinical practice. It offers a way to deliver systemic anticancer therapies (SACT) and supportive care in patients’ homes under strict governance frameworks, keeping the consultant as the primary decision-maker.
Clinical leadership
The consultant remains the responsible clinician. Clinical treatment at home operates under consultant direction in accordance with their authorised protocols.
Sponsored and written by
- Treatment plans: Consultants determine the regimen, dosage, and schedule.
- Changes to therapy: Dose reductions, delays, or changes in therapy remain their clinical decision
- Escalation: Consultants set the parameters. Interventions are escalated via the agreed bespoke escalation pathways.
Where clinical treatment at home fits in the pathway
Clinical treatment at home is not suitable for every patient, but it offers significant value at specific integration points:
1. SACT
Many subcutaneous and intravenous therapies can be safely administered at home. For example, Lloyds Clinical reviews all SACT treatments following strict protocols and processes via our clinical governance committee.
2. Symptom management and supportive care
Integration extends beyond active treatment. Specialist nurses can visit patients to manage central venous access devices and administer supportive medications, as well as provide holistic care and support.
3. Mitigating treatment fatigue
For patients, the cumulative burden of travel and hospital waiting times can lead to treatment fatigue. Integrating home visits can significantly improve the patient experience and treatment adherence.
Governance, safety, and escalation
In England, providers of at-home cancer treatment are regulated by the Care Quality Commission, meeting rigorous standards for safety and effectiveness. Highly trained clinical teams have the expertise and equipment to respond as they would in hospital.
When integrating clinical treatment at home, the consultant should expect:
- Rigorous clinical governance: Protocols that align with UK Oncology Nursing Society (UKONS) guidelines and national best practices.
- Defined escalation pathways: Clear, pre-agreed routes for managing acute reactions or clinical deterioration.
- Audit and reporting: Transparent reporting of incidents, outcomes, and patient satisfaction data.
Communication and information flow
A robust private pathway relies on seamless information exchange. Consultants know what is happening with their patients in real time. Effective processes combined with digital technology innovations facilitate:
- Updates: Confirmation of treatment being administered
- Reporting: Clinical notes from home visits are accessible
- Feedback: Regular touchpoints to review patient progress and adjust care plans
The benefits of integrating clinical treatment at home
Integrating at-home care offers distinct advantages for both the consultant and the patient.
For the consultant, it offers flexibility, releasing capacity in the day unit or clinic, allowing the consultant to prioritise new or complex patients. Consultants remain in control with complete clinical oversight, with safety and clinical governance at its heart.
For patients, treatment at home removes the strain of unnecessary travel, car parking, and hospital visits, freeing up time for patients to prioritise family life and work. Patients receive consistent care from specialist nurses in a familiar environment.
